GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (XSWX:RLF) » Definitions » PS Ratio

Relief Therapeutics Holding (XSWX:RLF) PS Ratio : 2.33 (As of Apr. 26, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Relief Therapeutics Holding PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Relief Therapeutics Holding's share price is CHF1.25. Relief Therapeutics Holding's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was CHF0.54. Hence, Relief Therapeutics Holding's PS Ratio for today is 2.33.

Good Sign:

Relief Therapeutics Holding SA stock PS Ratio (=2.28) is close to 5-year low of 2.19

The historical rank and industry rank for Relief Therapeutics Holding's PS Ratio or its related term are showing as below:

XSWX:RLF' s PS Ratio Range Over the Past 10 Years
Min: 0.04   Med: 0.91   Max: 2109.09
Current: 2.29

During the past 13 years, Relief Therapeutics Holding's highest PS Ratio was 2109.09. The lowest was 0.04. And the median was 0.91.

XSWX:RLF's PS Ratio is ranked better than
82.18% of 993 companies
in the Biotechnology industry
Industry Median: 8.92 vs XSWX:RLF: 2.29

Relief Therapeutics Holding's Revenue per Sharefor the six months ended in Jun. 2023 was CHF0.27. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was CHF0.54.

Warning Sign:

Relief Therapeutics Holding SA revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Relief Therapeutics Holding was -18.30% per year.

During the past 13 years, Relief Therapeutics Holding's highest 3-Year average Revenue per Share Growth Rate was 175.10% per year. The lowest was -65.50% per year. And the median was 110.15% per year.

Back to Basics: PS Ratio


Relief Therapeutics Holding PS Ratio Historical Data

The historical data trend for Relief Therapeutics Holding's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding PS Ratio Chart

Relief Therapeutics Holding Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.91 - - 67.24 20.87

Relief Therapeutics Holding Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 67.24 - 20.87 -

Competitive Comparison of Relief Therapeutics Holding's PS Ratio

For the Biotechnology subindustry, Relief Therapeutics Holding's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Relief Therapeutics Holding's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Relief Therapeutics Holding's PS Ratio distribution charts can be found below:

* The bar in red indicates where Relief Therapeutics Holding's PS Ratio falls into.



Relief Therapeutics Holding PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Relief Therapeutics Holding's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=1.25/0.537
=2.33

Relief Therapeutics Holding's Share Price of today is CHF1.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Relief Therapeutics Holding's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was CHF0.54.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Relief Therapeutics Holding  (XSWX:RLF) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Relief Therapeutics Holding PS Ratio Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Relief Therapeutics Holding (XSWX:RLF) Business Description

Traded in Other Exchanges
Address
Avenue de Secheron 15, Fondation EIP, Batiment, Geneva, CHE, CH-1202
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Geographically group generates the majority of its revenue from Europe.

Relief Therapeutics Holding (XSWX:RLF) Headlines

No Headlines